PI-RADS, Active Surveillance Protocols for 3+3=6 & 3+4=7, & Genomic/Genetics Tests | Mark Scholz, MD

PCRI's Alex asks questions from our helpline and YouTube comments on the topics of PI-RADS, Gleason 3+4=7 when the percentage of 4 is less than 10%, and active surveillance.

0:10 What is PI-RADS?

1:39 When a biopsy result of 3+4=7 and the percentage of 4 is lower than 10%, how often does it occur that the interpretation of 4 is a mistake?

4:55 What is the optimal monitoring process for patients on active surveillance and does it differ between individuals with 3+3=6 versus 3+4=7?

6:30 How does the monitoring process change over time for men on active surveillance?

7:03 How long can patients potentially stay on active surveillance?

7:29 Which genomic/genetic tests do you recommend patients seek out?

Don’t know your stage? Take the quiz: Visit http://www.prostatecancerstaging.org

To learn more about prostate cancer visit http://www.pcri.org

Sign up for our newsletter here to receive the latest updates on prostate cancer and the PCRI: https://pcri.org/join

Who we are:

The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians, for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better individualized care. Feel free to explore our website or call our free helpline at 1 (800) 641-7274 with any questions that you have. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors.

The information on the Prostate Cancer Research Institute's YouTube channel is provided with the understanding that the Institute is not engaged in rendering medical advice or recommendation. The information provided in these videos should not replace consultations with qualified health care professionals to meet your individual medical needs.

#ProstateCancer #Prostate #MarkScholzMD